Avid Bioservices (Avid Bioservices) Change In Payables And Accrued Expense : $-1.7 Mil (TTM As of Oct. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Avid Bioservices Change In Payables And Accrued Expense?

Avid Bioservices's Change In Payables And Accrued Expense for the quarter that ended in Oct. 2023 was $-1.6 Mil. It means Avid Bioservices's Accounts Payable & Accrued Expense declined by $1.6 Mil from Jul. 2023 to Oct. 2023 .

Avid Bioservices's Change In Payables And Accrued Expense for the fiscal year that ended in Apr. 2023 was $2.1 Mil. It means Avid Bioservices's Accounts Payable & Accrued Expense increased by $2.1 Mil from Apr. 2022 to Apr. 2023 .

Avid Bioservices Change In Payables And Accrued Expense Historical Data

The historical data trend for Avid Bioservices's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Change In Payables And Accrued Expense Chart

Avid Bioservices Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

2.46

0.76

5.39

-0.04

2.08

Avid Bioservices Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															1.59	0.35	-1.64	1.22	-1.65

Avid Bioservices Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.7 Mil.

Avid Bioservices Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Avid Bioservices (Avid Bioservices) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMO) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

TEHN:Germany

Address

14191 Myford Road, Tustin, CA, USA, 92780

Website

https://www.avidbio.com

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Executives

Matthew R. Kwietniak	officer: Chief Commercial Officer	14191 MYFORD ROAD, TUSTIN CA 92780
Richard A. Richieri	officer: Chief Operations Officer	14191 MYFORD ROAD, TUSTIN CA 92780
Daniel Ryan Hart	officer: Chief Financial Officer	2642 MICHELLE DR., SUITE 200, TUSTIN CA 62780
Mark R Ziebell	officer: V.P., General Counsel	14282 FRANKLIN AVENUE, TUSTIN CA 92780
Richard B Hancock	director	14282 FRANKLIN AVE., TUSTIN CA 92780
Joseph Carleone	director	3883 HOWARD HUGHES PKWY, SUITE 700, LAS VEGAS NV 89169
Nicholas Stewart Green	director, officer: President & CEO	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Gregory Sargen	director
Esther M. Alegria	director	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Mark R Bamforth	director	500 KENDALL ST., CAMBRIDGE MA 02142
Jeanne Thoma	director	C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE MN 56623
Patrick D Walsh	director	14282 FRANKLIN AVE., TUSTIN CA 92780
Catherine J Mackey	director	3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
Joel Mccomb	director	9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121
Stephen Michael Hedberg	officer: Principal Fin. & Acct. Officer	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780